An observational study in Neural Tube Defects and Folic Acid, sponsored by Karabuk University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.
Sponsored by Karabuk University · Observational
Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to express the level of knowledge of the determined population on this subject and to present ideas to increase awareness in the society.
52 studies on the registry are indexed under Neural Tube Defects; 11 are open to participants now.
This study's enrollment of 267 is above the median of 123 across 24 observational studies indexed under Neural Tube Defects.
Browse Neural Tube Defects studies →Karabuk University is the lead sponsor of 131 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Singleton pregnant women over the age of 18 and under the age of 45 who have at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth history with aneuploidy, history of GDM or known DM).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Singleton pregnant women over the age of 18 and under the age of 45 who have at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth history with aneuploidy, history of GDM or known DM).
Singleton pregnant women over 18 years of age and under 45 years of age who do not have any risk factors for neural tube defects
High awareness level for high-risk pregnant women
Pregnant women with at least one risk factor for neural tube defects have statistically higher folic acid use and awareness than control group pregnant women.
Time frame: up to 12 weeks
Low awareness level for society, regardless of the risk situation
Low folic acid knowledge and awareness in the sample groups, regardless of risk status
Time frame: up to 12 weeks
Ran from Feb 2023 to primary completion in Aug 2023, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.